Pharmaceutical composition for weight reduction or metabolic syndrome treatment
作者： Wang Chuanxiu
DOI:
关键词:
摘要: The invention relates to a pharmaceutical composition for weight reduction or metabolic syndrome treatment, belongs the field of medicine and particularly containing orlistat cetilistat rosiglitazone hydrochloride, wherein is solid preparations such as common tablets, dispersible sustained release capsules granules. An accidental discovery in experiments shows that hydrochloride significantly synergistically functional lowering blood sugar reducing weight, preparation method simple, operating convenient, suitable industrial production.
lens.org 参考文章(3)
Nageswara R. Palepu, Combinations of statins and anti-obesity agent and glitazones ,(2008)
Parvaneh Rahimi-Moghaddam, SoltanAhmad Ebrahimi, Fariborz Keyhanfar, AshrafSadat Moazzam, Marjan Emzhik, Commentary on prevention a possible drug-drug interaction: is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity? International Journal of Preventive Medicine. ,vol. 6, pp. 16- 16 ,(2015) , 10.4103/2008-7802.151825
Guoliang Cheng, Zhiquan Zhao, Medical composition for losing weight or treating metabolic syndromes ,(2010)